Phase I-II Study HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer With or Without Metastatic Disease
Phase of Trial: Phase I/II
Latest Information Update: 07 Jul 2016
Price : $35 *
At a glance
- Drugs Prostate cancer gene therapy (Primary) ; Valaciclovir (Primary) ; Ciprofloxacin
- Indications Prostate cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 29 Jun 2016 Status changed from active, no longer recruiting to recruiting.
- 16 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.